長期投資家のためのIR情報
バリュートレンド

【2689】オルバディーブイエックスヘルスケア
医療機器販売。中国地方、四国強い。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2026.06 2026/08/12 実 126,595 ↓ -1.1% -1.1% 1,679 ↓ -16.0% -16.0% 1,664 ↓ -13.7% -13.7% 1,112 ↓ -15.8% -15.8%
2026.06 2026/04/27 Q3予 127,978 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,928 → 0.0% 0.0% 1,321 → 0.0% 0.0%
2026.06 2026/01/30 Q2予 127,978 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,928 → 0.0% 0.0% 1,321 → 0.0% 0.0%
2026.06 2025/10/31 Q1予 127,978 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,928 → 0.0% 0.0% 1,321 → 0.0% 0.0%
2026.06 2025/08/12 当初予 127,978 - - - 2,000 - - - 1,928 - - - 1,321 - - -
2025.06 2025/08/12 実 122,702 ↓ -0.8% -0.8% 1,979 ↓ -12.8% -12.8% 1,962 ↓ -12.9% -12.9% 1,430 ↓ -2.4% -2.4%
2025.06 2025/04/30 Q3予 123,726 → 0.0% 0.0% 2,270 → 0.0% 0.0% 2,253 → 0.0% 0.0% 1,465 → 0.0% 0.0%
2025.06 2025/01/31 Q2予 123,726 → 0.0% 0.0% 2,270 → 0.0% 0.0% 2,253 → 0.0% 0.0% 1,465 → 0.0% 0.0%
2025.06 2024/10/31 Q1予 123,726 → 0.0% 0.0% 2,270 → 0.0% 0.0% 2,253 → 0.0% 0.0% 1,465 → 0.0% 0.0%
2025.06 2024/08/09 当初予 123,726 - - - 2,270 - - - 2,253 - - - 1,465 - - -
2024.06 2024/08/09 実 118,564 ↑ +0.2% +0.2% 2,226 ↑ +1.2% +1.2% 2,244 ↑ +1.6% +1.6% 1,500 ↑ +3.4% +3.4%
2024.06 2024/04/30 Q3予 118,386 → 0.0% 0.0% 2,200 → 0.0% 0.0% 2,209 → 0.0% 0.0% 1,451 → 0.0% 0.0%
2024.06 2024/01/31 Q2予 118,386 → 0.0% 0.0% 2,200 → 0.0% 0.0% 2,209 → 0.0% 0.0% 1,451 → 0.0% 0.0%
2024.06 2023/10/31 Q1予 118,386 → 0.0% 0.0% 2,200 → 0.0% 0.0% 2,209 → 0.0% 0.0% 1,451 → 0.0% 0.0%
2024.06 2023/08/09 当初予 118,386 - - - 2,200 - - - 2,209 - - - 1,451 - - -
2023.06 2023/08/09 実 110,472 ↑ +0.9% +0.9% 2,151 ↑ +7.5% +7.5% 2,158 ↑ +8.0% +8.0% 1,414 ↑ +8.0% +8.0%
2023.06 2023/04/28 Q3予 109,479 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,998 → 0.0% 0.0% 1,309 → 0.0% 0.0%
2023.06 2023/01/31 Q2予 109,479 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,998 → 0.0% 0.0% 1,309 → 0.0% 0.0%
2023.06 2022/10/31 Q1予 109,479 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,998 → 0.0% 0.0% 1,309 → 0.0% 0.0%
2023.06 2022/08/09 当初予 109,479 - - - 2,000 - - - 1,998 - - - 1,309 - - -
2022.06 2022/08/09 実 107,959 ↑ +0.4% +2.8% 2,073 ↑ +3.6% +29.8% 2,119 ↑ +4.4% +31.2% 1,535 ↑ +5.1% +45.9%
2022.06 2022/04/28 Q3予 107,500 ↑ +2.3% +2.3% 2,000 ↑ +25.2% +25.2% 2,030 ↑ +25.7% +25.7% 1,460 ↑ +38.8% +38.8%
2022.06 2022/01/31 Q2予 105,049 → 0.0% 0.0% 1,597 → 0.0% 0.0% 1,615 → 0.0% 0.0% 1,052 → 0.0% 0.0%
2022.06 2021/10/29 Q1予 105,049 → 0.0% 0.0% 1,597 → 0.0% 0.0% 1,615 → 0.0% 0.0% 1,052 → 0.0% 0.0%
2022.06 2021/08/10 当初予 105,049 - - - 1,597 - - - 1,615 - - - 1,052 - - -
2021.06 2021/08/10 実 112,976 ↓ -1.0% -1.0% 1,540 ↑ +6.9% +6.9% 1,542 ↑ +7.0% +7.0% 989 ↑ +6.2% +6.2%
2021.06 2021/04/30 Q3予 114,114 → 0.0% 0.0% 1,440 → 0.0% 0.0% 1,441 → 0.0% 0.0% 931 → 0.0% 0.0%
2021.06 2021/01/29 Q2予 114,114 → 0.0% 0.0% 1,440 → 0.0% 0.0% 1,441 → 0.0% 0.0% 931 → 0.0% 0.0%
2021.06 2020/11/02 Q1予 114,114 → 0.0% 0.0% 1,440 → 0.0% 0.0% 1,441 → 0.0% 0.0% 931 → 0.0% 0.0%
2021.06 2020/08/11 当初予 114,114 - - - 1,440 - - - 1,441 - - - 931 - - -
2020.06 2020/08/11 実 107,896 ↓ -2.4% -2.4% 927 ↑ +3.0% -26.1% 905 ↓ -0.7% -28.5% 326 ↑ +7.6% -61.1%
2020.06 2020/04/30 Q3予 110,520 → 0.0% 0.0% 900 → 0.0% -28.2% 911 → 0.0% -28.0% 303 → 0.0% -63.8%
2020.06 2020/02/03 Q2予 110,520 → 0.0% 0.0% 900 → 0.0% -28.2% 911 → 0.0% -28.0% 303 → 0.0% -63.8%
2020.06 2020/01/24 修正予 110,520 → 0.0% 0.0% 900 ↓ -28.2% -28.2% 911 ↓ -28.0% -28.0% 303 ↓ -63.8% -63.8%
2020.06 2019/10/31 Q1予 110,520 → 0.0% 0.0% 1,254 → 0.0% 0.0% 1,265 → 0.0% 0.0% 837 → 0.0% 0.0%
2020.06 2019/08/09 当初予 110,520 - - - 1,254 - - - 1,265 - - - 837 - - -
2019.06 2019/08/09 実 107,428 ↓ -3.1% -3.1% 1,301 ↓ -1.7% -1.7% 1,309 ↓ -2.0% -2.0% 775 ↓ -10.0% -10.0%
2019.06 2019/04/26 Q3予 110,881 → 0.0% 0.0% 1,324 → 0.0% 0.0% 1,336 → 0.0% 0.0% 861 → 0.0% 0.0%
2019.06 2019/01/31 Q2予 110,881 → 0.0% 0.0% 1,324 → 0.0% 0.0% 1,336 → 0.0% 0.0% 861 → 0.0% 0.0%
2019.06 2018/10/31 Q1予 110,881 → 0.0% 0.0% 1,324 → 0.0% 0.0% 1,336 → 0.0% 0.0% 861 → 0.0% 0.0%
2019.06 2018/08/09 当初予 110,881 - - - 1,324 - - - 1,336 - - - 861 - - -
2018.06 2018/08/09 実 107,663 ↓ -0.0% +1.2% 1,230 ↑ +0.8% +11.8% 1,235 ↑ +0.4% +11.4% 1,054 ↑ +1.3% +47.6%
2018.06 2018/07/13 修正予 107,670 ↑ +1.2% +1.2% 1,220 ↑ +10.9% +10.9% 1,230 ↑ +10.9% +10.9% 1,040 ↑ +45.7% +45.7%
2018.06 2018/04/27 Q3予 106,377 → 0.0% 0.0% - - - - 1,109 → 0.0% 0.0% 714 → 0.0% 0.0%
2018.06 2018/01/30 Q2予 106,377 → 0.0% 0.0% 1,100 → 0.0% 0.0% 1,109 → 0.0% 0.0% 714 → 0.0% 0.0%
2018.06 2017/10/31 Q1予 106,377 → 0.0% 0.0% 1,100 → 0.0% 0.0% 1,109 → 0.0% 0.0% 714 → 0.0% 0.0%
2018.06 2017/08/09 当初予 106,377 - - - 1,100 - - - 1,109 - - - 714 - - -
2017.06 2017/08/09 実 105,778 ↑ +0.7% +0.7% 1,044 ↑ +4.4% +27.9% 1,112 ↑ +4.9% +37.6% 690 ↑ +4.5% +40.2%
2017.06 2017/04/28 Q3予 105,069 → 0.0% 0.0% 1,000 ↑ +22.5% +22.5% 1,060 ↑ +31.2% +31.2% 660 ↑ +34.1% +34.1%
2017.06 2017/01/31 Q2予 105,069 → 0.0% 0.0% 816 → 0.0% 0.0% 808 → 0.0% 0.0% 492 → 0.0% 0.0%
2017.06 2016/10/28 Q1予 105,069 → 0.0% 0.0% 816 → 0.0% 0.0% 808 → 0.0% 0.0% 492 → 0.0% 0.0%
2017.06 2016/08/09 当初予 105,069 - - - 816 - - - 808 - - - 492 - - -
2016.06 2016/08/09 実 101,460 ↑ +1.6% -1.5% 543 ↑ +19.9% -22.4% 556 ↑ +24.1% -19.2% 305 ↑ +39.3% -17.3%
2016.06 2016/04/28 Q3予 99,833 → 0.0% -3.1% 453 → 0.0% -35.3% 448 → 0.0% -34.9% 219 → 0.0% -40.7%
2016.06 2016/01/28 Q2予 99,833 ↓ -3.1% -3.1% 453 ↓ -35.3% -35.3% 448 ↓ -34.9% -34.9% 219 ↓ -40.7% -40.7%
2016.06 2015/10/29 Q1予 103,020 → 0.0% 0.0% 700 → 0.0% 0.0% 688 → 0.0% 0.0% 369 → 0.0% 0.0%
2016.06 2015/08/10 当初予 103,020 - - - 700 - - - 688 - - - 369 - - -
2015.06 2015/08/10 実 94,515 ↓ -0.8% -6.5% 668 ↓ -0.4% -56.5% 662 ↓ -0.2% -56.5% 405 ↑ +18.1% -54.4%
2015.06 2015/04/30 Q3予 95,307 → 0.0% -5.7% 671 → 0.0% -56.3% 663 → 0.0% -56.4% 343 → 0.0% -61.4%
2015.06 2015/01/29 Q2予 95,307 ↓ -5.7% -5.7% 671 ↓ -56.3% -56.3% 663 ↓ -56.4% -56.4% 343 ↓ -61.4% -61.4%
2015.06 2014/10/30 Q1予 101,091 → 0.0% 0.0% 1,537 - - - 1,521 → 0.0% 0.0% 889 → 0.0% 0.0%
2015.06 2014/08/08 当初予 101,091 - - - - - - - 1,521 - - - 889 - - -
2014.06 2014/08/08 実 - - - - - - - - - - - - - - - -
2014.06 2014/04/30 当初予 96,842 - - - 1,450 - - - 1,491 - - - 787 - - -
シェア ツイート
ページトップへ戻る